Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The horseshoe crab has been scuttling in the ocean and tidal pools for more than 400 million years, playing a vital role in the East Coast ecosystem along with being a prized item for fishing bait and medical research.
The Biden administration is launching a trial for a new payment program for people and organizations providing caregiving coordination services to dementia patients on Medicare.
Since 2010, at least 100,000 people bitten by a lone star tick have become allergic to mammal meat, milk and other mammal-derived products such as gelatin.
